BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Gastric cancer AND ERCC5, XPGC, 2073, ENSG00000134899, RP11-484I6_5, COFS3, XPG, UVDR, ERCM2 AND Prognosis
5219 results:

  • 1. Predictors of 1-year mortality after gastrectomy for gastric cancer.
    Sekimoto A; Miyake H; Nagai H; Yoshioka Y; Yuasa N
    World J Surg; 2024 Jan; 48(1):138-150. PubMed ID: 38686784
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Characteristics of early gastric tumors with different differentiation and predictors of long-term outcomes after endoscopic submucosal dissection.
    Zhu HY; Wu J; Zhang YM; Li FL; Yang J; Qin B; Jiang J; Zhu N; Chen MY; Zou BC
    World J Gastroenterol; 2024 Apr; 30(14):1990-2005. PubMed ID: 38681129
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Modified Q-type purse-string suture duodenal stump embedding method for laparoscopic gastrectomy for gastric cancer.
    Sun L; Wang W; Zhou J; Ji L; Zhao S; Fu Y; Li R; Wang J; Qian C; Sun Q; Wang D
    BMC Surg; 2024 Apr; 24(1):123. PubMed ID: 38658911
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Endoscopic manifestation of intestinal transplant-associated microangiopathy after stem cell transplantation.
    Iwamuro M; Ennishi D; Fujii N; Matsuoka KI; Tanaka T; Inokuchi T; Hiraoka S; Otsuka M
    BMC Gastroenterol; 2024 Apr; 24(1):140. PubMed ID: 38649868
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Real-world evidence of treatment patterns and survival of metastatic gastric cancer patients in Germany.
    Luna J; Picker N; Wilke T; Lutz M; Hess J; Mörtl B; Xiong Y; Götze TO
    BMC Cancer; 2024 Apr; 24(1):462. PubMed ID: 38614966
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. CircNRD1 elevates THAP domain containing 11 through sequestering microRNA-421 to inhibit gastric cancer growth and tumorigenesis.
    Liu A; Liang J; Wen J
    J Biochem Mol Toxicol; 2024 Apr; 38(4):e23705. PubMed ID: 38602237
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Metastasis patterns and prognosis in young gastric cancer patients: A propensity score‑matched SEER database analysis.
    Zhang H; Cheng X; Guo W; Zheng C; Zhang Y; Jing X; Qiao H
    PLoS One; 2024; 19(4):e0301834. PubMed ID: 38593111
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. HSPA4 upregulation induces immune evasion via ALKBH5/CD58 axis in gastric cancer.
    Suo D; Gao X; Chen Q; Zeng T; Zhan J; Li G; Zheng Y; Zhu S; Yun J; Guan XY; Li Y
    J Exp Clin Cancer Res; 2024 Apr; 43(1):106. PubMed ID: 38589927
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The role of cytoreductive surgery and HIPEC for the treatment of primary and secondary peritoneal malignancies-experience from a tertiary care center in Germany.
    Reese M; Eichelmann AK; Nowacki TM; Pascher A; Sporn JC
    Langenbecks Arch Surg; 2024 Apr; 409(1):113. PubMed ID: 38589714
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. A retrospective study: exploring the optimal patient population for adjuvant chemotherapy after D2 gastrectomy.
    Zheng Y; Ma Y; Pang C; Yin K; Liu K; Chen J; Zi M; Wei Y; Cheng X; Yuan L
    J Gastrointest Surg; 2024 Apr; 28(4):365-374. PubMed ID: 38583885
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. GGT5 facilitates migration and invasion through the induction of epithelial-mesenchymal transformation in gastric cancer.
    Luo Z; Chen Y; Chen B; Zhao Z; Wu R; Ren J
    BMC Med Genomics; 2024 Apr; 17(1):82. PubMed ID: 38581025
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Lymphovascular invasion is associated with poor long-term outcomes in patients with pT1N0-3 or pT2-3N0 remnant gastric cancer: a retrospective cohort study.
    Sumiyoshi S; Ohashi T; Kubota T; Nishibeppu K; Owada K; Kiuchi J; Shimizu H; Arita T; Iitaka D; Yamamoto Y; Konishi H; Morimura R; Watanabe K; Kuriu Y; Shiozaki A; Ikoma H; Fujiwara H; Yamaoka N; Otsuji E
    World J Surg Oncol; 2024 Apr; 22(1):86. PubMed ID: 38581014
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Integrated analysis of single-cell and bulk RNA-sequencing reveals a novel signature based on NK cell marker genes to predict prognosis and immunotherapy response in gastric cancer.
    Sun JR; Kong CF; Ye YX; Wang Q; Qu XK; Jia LQ; Wu S
    Sci Rep; 2024 Apr; 14(1):7648. PubMed ID: 38561388
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. [Colorectal adenocarcinoma with enteroblastic differentiation: a clinicopathological analysis of eight cases].
    Wang Q; Zhang Y; Tan C; Ni SJ; Huang D; Chang B; Sheng WQ; Wang L
    Zhonghua Bing Li Xue Za Zhi; 2024 Apr; 53(4):370-376. PubMed ID: 38556821
    [No Abstract]    [Full Text] [Related]  

  • 15. Identification of Hub Genes and Potential Pathogenesis in gastric cancer Based on Integrated Gene Expression Profile Analysis.
    Luu Truong Thanh H; Hoang TM; Hoang Van H
    Asian Pac J Cancer Prev; 2024 Mar; 25(3):885-892. PubMed ID: 38546071
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Nomogram for Predicting Infectious Complications Following Curative Gastrectomy Using Clinical and Laboratory Parameters.
    Hwang SH; Kim DJ
    Anticancer Res; 2024 Apr; 44(4):1781-1790. PubMed ID: 38537986
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. First-line camrelizumab (a PD-1 inhibitor) plus apatinib (an VEGFR-2 inhibitor) and chemotherapy for advanced gastric cancer (SPACE): a phase 1 study.
    Chen X; Xu H; Chen X; Xu T; Tian Y; Wang D; Guo F; Wang K; Jin G; Li X; Wang R; Li F; Ding Y; Tang J; Fang Y; Zhao J; Liu L; Ma L; Meng L; Hou Z; Zheng R; Liu Y; Guan N; Zhang B; Tong S; Chen S; Li X; Shu Y
    Signal Transduct Target Ther; 2024 Mar; 9(1):73. PubMed ID: 38528050
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Validation of CDC45 as a novel biomarker for diagnosis and prognosis of gastric cancer.
    Wu L; Gao G; Mi H; Luo Z; Wang Z; Liu Y; Wu L; Long H; Shen Y
    PeerJ; 2024; 12():e17130. PubMed ID: 38515458
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Peritoneal Tumor DNA as a Prognostic Biomarker in gastric cancer: A Systematic Review and Meta-Analysis.
    Allan Z; Witts S; Wong DJ; Lee MM; Tie J; Tebbutt NC; Clemons NJ; Liu DS
    JCO Precis Oncol; 2024 Mar; 8():e2300546. PubMed ID: 38513167
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. TMEM120B strengthens breast cancer cell stemness and accelerates chemotherapy resistance via β1-integrin/FAK-TAZ-mTOR signaling axis by binding to MYH9.
    Hu R; Cao Y; Wang Y; Zhao T; Yang K; Fan M; Guan M; Hou Y; Ying J; Ma X; Deng N; Sun X; Zhang Y; Zhang X
    Breast Cancer Res; 2024 Mar; 26(1):48. PubMed ID: 38504374
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 261.